+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Methotrexate transport and resistance



Methotrexate transport and resistance



Leukemia and Lymphoma 30(3-4): 215-224



Methotrexate (MTX), the antifolate drug widely used as both an anticancer chemotherapeutic drug and as an immunosuppressive agent, mimics natural folates to inhibit critical cellular biosynthetic pathways. One of the most important determinants of cellular sensitivity to MTX is the degree to which this drug is internalized by cancer cells, and one of the major pathways of folate uptake results from the activity of the reduced folate carrier (RFC). Decreased RFC activity has been associated with several models of transport-mediated MTX resistance. Recently, the rodent and human genes which encode this protein have been isolated (RFC1), and defects in the expression of RFC1 genes have been identified in transport-deficient, MTX-resistant cell lines. Therefore, these studies have demonstrated the importance of RFC1 expression in transport-mediated antifolate drug resistance. In addition, however, studies of both MTX uptake in cancer cells and of folate transport in physiologic systems indicate that there are other proteins with uptake characteristics similar to RFC, and which maybe encoded by genes other than RFC1.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 046676761

Download citation: RISBibTeXText

PMID: 9713954

DOI: 10.3109/10428199809057535


Related references

The effect of low pH on breast cancer resistance protein (ABCG2)-mediated transport of methotrexate, 7-hydroxymethotrexate, methotrexate diglutamate, folic acid, mitoxantrone, topotecan, and resveratrol in in vitro drug transport models. Molecular Pharmacology 71(1): 240-249, 2006

Elevated dihydrofolate reductase and impaired methotrexate transport as elements in methotrexate resistance in childhood acute lymphoblastic leukemia. Blood 85(2): 500-509, 1995

Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system. Cancer Research 62(11): 3144-3150, 2002

Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport. Cancer Research 63(14): 4048-4054, 2003

Characterization of transport-mediated methotrexate resistance in human tumor cells with antibodies to the membrane carrier for methotrexate and tetrahydrofolate cofactors. Journal of Biological Chemistry 267(32): 23253-23260, 1992

Characterization of transport-mediated methotrexate resistance in human leukemia cells with antibodies to the classical membrane carrier for methotrexate and tetrahydrofolate cofactors. Leukemia 6(10): 1086, 1992

Transport of methotrexate and folates by multidrug resistance protein 3 and MRP1 Effect of polyglutamylation on MTX transport. Cancer Research 61(19): 7225-7232, October 1, 2001

Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport. Cancer Research 61(19): 7225-7232, 2001

The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate. Clinical Cancer Research 6(9): 3687-3695, 2000

Transport of methotrexate and E217betaG by ABCG2 Effects of variation at amino acid position 482 and polyglutamylation on methotrexate transport. Proceedings of the American Association for Cancer Research Annual Meeting 44: 113, 2003

The molecular mechanism of resistance to methotrexate in mouse methotrexate-resistant cells by cancer drug resistance and metabolism SuperArray. Basic and Clinical Pharmacology and Toxicology 99(2): 141-145, 2006

Evidence for multiple mechanisms of methotrexate resistance in cells displaying atypical multidrug resistance following selection solely with high concentration methotrexate. Proceedings of the American Association for Cancer Research Annual Meeting 31: 372, 1990

In vitro transport of methotrexate by Drosophila Multidrug Resistance-associated Protein. Plos One 13(10): E0205657, 2018

Transport of fluorescein methotrexate by multidrug resistance-associated protein 3 in IEC-6 cells. American Journal of Physiology. Gastrointestinal and Liver Physiology 285(3): G602-G610, 2003

Mechanisms of methotrexate resistance in acute leukemia. Decreased transport and polyglutamylation. Advances in Experimental Medicine and Biology 457: 543-550, 1999